pharmaceuticals

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

It is not unusual for big biotech and pharmaceutical companies to sign research and development pacts with smaller companies and smaller entities. These pacts often come with big price tags ...
Read Full Story »

Why Spectrum Pharmaceuticals Shares Are Surging

Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) saw its shares make a solid gain early on Wednesday after the firm announced interim data from its mid-stage trial for the treatment of non-small ...
Read Full Story »

Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth

Johnson & Johnson (NYSE: JNJ) reported its fiscal third-quarter financial results before the markets opened on Tuesday. The company said that it had $1.90 in earnings per share (EPS) and ...
Read Full Story »

Why Infinity Pharmaceuticals Shares Are Surging

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) saw its shares almost double early on Thursday after the company announced that an abstract from its ongoing clinical trial of IPI-549 had been selected ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

KalVista Pharma Wins Big on Merck Collaboration

KalVista Pharmaceuticals Inc. (NASDAQ: KALV) saw its shares absolutely explode early on Tuesday after it was announced that the firm would be collaborating with Merck & Co. Inc. (NYSE: MRK). ...
Read Full Story »

Even More Biopharma and FDA Catalysts Coming in October

As the markets continue to hit all-time highs, biotech and pharmaceutical companies have been part of these massive gains. There is a very positive sentiment in the health care sector ...
Read Full Story »

Why ImmunoGen’s Secondary Makes Sense

ImmunoGen Inc. (NASDAQ: IMGN) saw its shares make a sharp turn downward early Thursday morning after the stock has seen an incredible year of trading so far. Shares taking a ...
Read Full Story »

Is This the Turnaround That Mylan Has Waited For?

Finally some good news out of Mylan N.V. (NASDAQ: MYL), which is potentially bringing the shares back to about even for 2017. The pharmaceutical firm announced that the U.S. Food ...
Read Full Story »

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. The firm is looking at pharma and biotech opportunities around politics, drug pipelines and ...
Read Full Story »

Why Morgan Stanley Sees Over 30% Upside in Sarepta

Shares of Sarepta Therapeutics Inc. (NASDAQ: SRPT) saw a handy gain on Monday after the firm received an upgrade from Morgan Stanley. The driving force behind this upgrade is Sarepta’s ...
Read Full Story »

FDA Update Keeps Rigel Pharmaceuticals Above Water

Shares of Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) saw a solid gain to start off the week after the company gave an update from its meeting with the U.S. Food and ...
Read Full Story »

Major Biotech, Pharma and FDA Catalysts Coming in October

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »

Why Zogenix Shares More Than Doubled

Zogenix Inc. (NASDAQ: ZGNX) saw its shares more than double early on Friday after the company reported positive top-line results from its most recent late-stage trial in the treatment of ...
Read Full Story »

AbbVie and Amgen Reach Global Resolution of Humira

AbbVie Inc. (NYSE: ABBV) shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes with Amgen Inc. (NASDAQ: AMGN). What’s important ...
Read Full Story »